Table 1.
Characteristics of Study Population
| Characteristic | Females n = 39 |
Males n = 19 |
|---|---|---|
| Age (years) | (%) | (%) |
| 18–34 | 5.1 | 0.0 |
| 35–49 | 20.5 | 15.8 |
| 50–59 | 28.2 | 5.3 |
| 60–69 | 25.6 | 47.4 |
| ≥ 70 | 20.5 | 31.6 |
| Ethnicity | ||
| Hispanic | 15.8 | 11.1 |
| non-Hispanic | 84.2 | 88.9 |
| Race | ||
| Caucasian, non-Hispanic | 61.5 | 57.9 |
| African-American, non-Hispanic | 7.7 | 5.3 |
| Chinese, non-Hispanic | 0.0 | 5.3 |
| Filipino, non-Hispanic | 5.1 | 0.0 |
| Other Asian, non-Hispanic | 0.0 | 5.3 |
| Bi-racial, non-Hispanic | 5.1 | 0.0 |
| American-Indian, non-Hispanic | 2.6 | 10.5 |
| Other | 17.9 | 13.3 |
| Education | ||
| High school or less | 18.4 | 26.3 |
| Some college or greater | 81.6 | 73.7 |
| Household income | ||
| $50,000 or less | 53.9 | 26.3 |
| ≥ $50,000 | 46.2 | 73.7 |
| Cancer Diagnosis | ||
| Breast | 41.0 | 0.0 |
| Colon/rectal | 15.4 | 15.8 |
| Leukemia | 0.0 | 5.3 |
| Lung | 10.3 | 10.5 |
| Melanoma | 5.1 | 5.3 |
| Non-Hodgkin Lymphoma | 10.3 | 10.5 |
| Ovarian | 10.3 | 0.0 |
| Prostate | 0.0 | 26.3 |
| Other | 7.7 | 26.3 |
| Experienced recurrence | ||
| Yes | 34.2 | 15.8 |
| No | 65.8 | 84.2 |
| Conventional Treatment | ||
| Chemotherapy, exclusively | 15.4 | 15.8 |
| Combination therapy | 84.6 | 84.2 |